Furthermore, we examined whether the universal pegRNA could correct the endogenous KRAS mutations in three types of human cancer cells: two pancreatic cancer cell lines, CFPAC-1 and ASPC-1, and one colon cancer cell line, HCT11627,28. The gene discussed is KRAS; the disease is malignant colon neoplasm.